Review of the Mechanisms of Action of the Statins and Their Pleiotropic Effects in the Treatment of Hypercholesterolemia and Atherosclerosis
Review of the Mechanisms of Action of the Statins and Their Pleiotropic Effects in the Treatment of Hypercholesterolemia and Atherosclerosis
摘要
Statins are lipid-lowering agents widely used in the treatment of hypercholesterolemia and atherosclerosis. They act by inhibiting of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase, an enzyme responsible for the conversion of HMG-CoA to mevalonate in cholesterol biosynthesis. Due to their ability to reduce low-density lipoproteins (LDL) levels more than other cholesterol-lowering drugs, they have become the drugs most often prescribed in the treatment of atherosclerosis.
Statins are lipid-lowering agents widely used in the treatment of hypercholesterolemia and atherosclerosis. They act by inhibiting of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase, an enzyme responsible for the conversion of HMG-CoA to mevalonate in cholesterol biosynthesis. Due to their ability to reduce low-density lipoproteins (LDL) levels more than other cholesterol-lowering drugs, they have become the drugs most often prescribed in the treatment of atherosclerosis.
参考文献10
-
1Funatsu T,Suzuki K,Goto M,et al.Prolonged inhibition of cholesterol synthesis by atorvastatin inhibits apo B-100 and triglyceride secretion from HepG2 cell[].Atherosclerosis.2001
-
2Bellosta S,Via D,Canavesi M,et al.HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophages[].Arteriosclerosis and Thrombosis.1998
-
3Laufs U,Fata VL,Plutzky J,et al.Upregulation of endothelial nitric oxide synthase by HMG-CoA reductase inhibitors[].Circulation.1998
-
4Bellosta S,Ferri N,Bernini F,et al.Non-lipid-related effects of statins[].Annals of Medicine.2000
-
5Vaughan CJ,Gotto AM,Basson CT.The evolving role of statins in the management of atherosclerosis[].Journal of the American College of Cardiology.2000
-
6Wagner AH,Kohler T,Ruckschloss U,et al.Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation[].Arteriosclerosis and Thrombosis.2000
-
7Brown MS,Goldstein JL.A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood[].Proceedings of the National Academy of Sciences of the United States of America.1999
-
8Corsini A,Bellosta S,Baetta R,et al.New insights into the pharmacodynamics and pharmacokinetic properties of statins[].Pharmacology and Therapeutics.1999
-
9Ross R.Atherosclerosis-an inflammatory disease[].The New England Journal of Medicine.1999
-
10Stancu C,Sima A.Statins: Mechanism of action and effects[].Journal of Cellular and Molecular Medicine.2001
-
1孙彦素,刘海东,孙素芬.辛伐他汀联用左旋氨氯地平对高血压患者血管内皮功能的影响[J].临床荟萃,2009,24(8):719-720. 被引量：2
-
2赵水平.他汀类药物调脂治疗[J].中国实用内科杂志,2003,23(8):510-511. 被引量：40
-
3骆雷鸣.老年人血脂异常治疗受益的证据[J].中国心血管杂志,2010,15(5):332-334.
-
4余国膺.他汀与前列腺癌危险:一项人群流行病学研究的结果[J].中国心脏起搏与心电生理杂志,2008,22(6):503-503.
-
5张鹏辉,李俊涛,李果明,王焱,郭志斌,郑克勤.HMG-CoA还原酶基因单核苷酸多态性与冠心病的关系[J].广东医学,2009,30(2):201-203. 被引量：1
-
6郭兰荣.阿托伐他汀治疗高脂血症的临床疗效[J].河北医科大学学报,2004,25(4):237-238. 被引量：2
-
7张鹏辉,李俊涛,李果明,王焱,郭志斌,郑克勤.HMG-CoA还原酶基因单核苷酸多态性与冠心病的关联研究[J].实用医药杂志,2008,25(12):1409-1411.
-
8童煜,张思仲,苏智广,孔祥东,施佳军,张立,张恒愉,张克兰.HMG-CoA还原酶基因多态性与血浆血脂的关系[J].中华医学遗传学杂志,2003,20(3):207-210. 被引量：5
-
9李闪,朱建华.他汀类药物在心肌肥厚治疗中的作用[J].中华心血管病杂志,2004,32(4):372-374. 被引量：39
-
10蔡海江.GENE THERAPY OF FAMILIAL HYPERCHOLESTEROLEMIA[J].Chinese Medical Journal,1996(2):8-10.
